Smooth muscle phenotypic modulation is an early event in aortic aneurysms

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 6, 2009, Pages 1392-1399

  Ailawadi, Gorav ^a   Moehle, Christopher W ^b   Pei, Hong ^a   Walton, Sandra P ^a   Yang, Zequan ^a   Kron, Irving L ^a   Lau, Christine L ^a   Owens, Gary K ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ELASTASE; GELATINASE A; GELATINASE B; SODIUM CHLORIDE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; AORTA; AORTA ANEURYSM; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PERFUSION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE FIBER; STAINING; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; AORTA; AORTA, ABDOMINAL; AORTIC ANEURYSM; AORTIC ANEURYSM, ABDOMINAL; DOWN-REGULATION; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; PANCREATIC ELASTASE; PHENOTYPE; POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 71649096360     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.07.075     Document Type: Article

References (25)

1. Ailawadi G., Eliason J.L., and Upchurch Jr. G.R. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 38 (2003) 584-588
2. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
3. Kawai-Kowase K., and Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292 (2007) C59-C69
4. Anidjar S., Salzmann J.L., Gentric D., Lagneau P., Camilleri J.P., and Michel J.B. Elastase-induced experimental aneurysms in rats. Circulation 82 (1990) 973-981
5. Ailawadi G., Eliason J.L., Roelofs K.J., et al. Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 24 (2004) 2116-2122
6. Eliason J.L., Hannawa K.K., Ailawadi G., et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112 (2005) 232-240
7. Layne M.D., Yet S.F., Maemura K., et al. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ Res 90 (2002) 728-736
8. Aikawa M., Sakomura Y., Ueda M., et al. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96 (1997) 82-90
9. Mack C.P., and Owens G.K. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ Res 84 (1999) 852-861
10. Manabe I., and Owens G.K. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest 107 (2001) 823-834
11. Miano J.M., Carlson M.J., Spencer J.A., and Misra R.P. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem 275 (2000) 9814-9822
12. Miano J.M., Long X., and Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292 (2007) C70-C81
13. Wamhoff B.R., Hoofnagle M.H., Burns A., Sinha S., McDonald O.G., and Owens G.K. A G/C element mediates repression of the SM22 alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res 95 (2004) 981-988
14. Liu Y., Sinha S., McDonald O.G., Shang Y., Hoofnagle M.H., and Owens G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280 (2005) 9719-9727
15. Yoshida T., Kaestner K.H., and Owens G.K. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 102 (2008) 1548-1557
16. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
17. Jones J.A., Spinale F.G., and Ikonomidis J.S. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 46 (2009) 119-137
18. Guo D.C., Pannu H., Tran-Fadulu V., et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 9 (2007) 1488-1493
19. Pannu H., Tran-Fadulu V., Papke C.L., et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 16 (2007) 2453-2462
20. Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
21. Dai J., Losy F., Guinault A.M., et al. Overexpression of transforming growth factor beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation 112 (2005) 1008-1015
22. Fukui D., Miyagawa S., Soeda J., Tanaka K., Urayama H., and Kawasaki S. Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 25 (2003) 540-545
23. Hautmann M.B., Adam P.J., and Owens G.K. Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol 19 (1999) 2049-2058
24. Martin J.S., Dickson M.C., Cousins F.M., Kulkarni A.B., Karlsson S., and Akhurst R.J. Analysis of homozygous TGF-beta 1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis. Ann N Y Acad Sci 752 (1995) 300-308
25. Sartore S., Chiavegato A., Faggin E., et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89 (2001) 1111-1121